BOSTON — Health care professionals should use a broad range of tools to diagnose diabetic peripheral neuropathy, and ...
Dr. Evan Norum, DC, BCN, from Advantage Neuropathy, joins us on The Morning Blend to discuss whether the condition is fatal ...
Dr. Jim Blanton from Blanton Chiropractic & Neuropathy stopped by First Look at Four with his patient, Richard Holland, to ...
Park says patient-specific factors that influence his treatment selection include the presence of liver disease, ...
This approval marks a milestone for high-risk sMM patients, but analyst Biswajit Podder notes that there are caveats to its ...
Enrollment to date of 100 patients, with 80 patients completing treatment in the ongoing Halneuron® Phase 2b trial, ...
The company will be available for one-on-one meetings during the conferences. Interested investors should contact their respective representative at the sponsoring institutions to request meetings.
For many people, neuropathy feels like a life sentence of pain. The burning, tingling, and numbness in the feet and legs make ...
The MarketWatch News Department was not involved in the creation of this content.-- VYVGART(R) SC is first and only neonatal Fc receptor blocker approved to treat CIDP -- Authoriz ...
A new nano-based drug delivery technology could outwit tuberculosis (TB)—one of humanity's most ancient diseases.
Akeso, Inc. (HKEX: 9926.HK) published the preclinical research data for its novel antagonistic monoclonal antibody targeting IL-1RAP, AK135, at the 40th Annual Meeting of the Society for Immunotherapy ...
Vertex Pharmaceuticals (VRTX) is rated as a "Strong Buy" due to robust revenue growth and multiple expansion opportunities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback